Skip to main content
CLPT
NASDAQ Industrial Applications And Services

ClearPoint Q3 Revenue Up 36% to $12.1M, But Net Loss Widens to $7.5M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$10.2
Mkt Cap
$322.125M
52W Low
$8.27
52W High
$27.27
52W Position info
23% above low
Off High info
63% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CLPT sits 23% above its 52-week low of $8.27.

Summary

ClearPoint's Q3 revenue rose 36% to $12.1 million, but the net loss widened to $7.5 million as gross margin fell to 58% and spending climbed. Cash of $46.2 million plus $27.5 million left on the ATM is stated to fund at least twelve months.


Key Events · Earnings and Guidance · CLPT

  • Q3 Revenue Jumps 36% to $12.1M

    Total revenue was $12.1 million versus $8.9 million a year earlier; neurosurgery navigation and therapy rose 59% to $5.4 million and capital equipment and software rose 68% to $1.7 million.

  • Net Loss Widens to $7.5M

    Q3 net loss was $7.46 million versus $5.89 million a year earlier; nine-month net loss reached $28.3 million versus $17.8 million.

  • Gross Margin Slips to 58%

    Gross margin fell from 63% to 58% on CAL facility overhead and $0.5 million of quarterly amortization of acquired intangibles.

  • ATM Sold 1.53M Shares for $22.0M

    1,530,000 shares were sold under the ATM in Q3 2026 for net proceeds of $22.0 million after $0.5 million of issuance costs; $27.5 million remains available.


Analysis · CLPT · Industrial Applications And Services

Revenue growth is real — neurosurgery navigation and therapy jumped 59% on the IRRAS acquisition and the 3.0 OR software — but the cost side moved faster. Gross margin slipped to 58% from 63% as the new CAL preclinical facility carries overhead and acquired intangibles amortize, and sales and marketing spending rose 44%. The result is a $7.5 million quarterly loss versus $5.9 million a year ago, and nine-month operating cash burn of $20.1 million against $11.8 million. To fund that gap, the company sold 1.53 million ATM shares for $22.0 million net, leaving $46.2 million of cash and $27.5 million still available on the ATM. Management says cash covers at least twelve months, so there is no near-term financing emergency — but the $50.8 million Oberland notes carry an 11.3% effective rate, PIK interest on the third tranche runs to March 2027, and revenue participation payments start in Q1 2027, all of which pull on cash as the PIK cushion ends.

How filings like this one have moved

In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CLPT was trading at $10.20 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $322.1M. The 52-week trading range was $8.27 to $27.27. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CLPT - Latest Insights

CLPT
Oct 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
CLPT
Aug 03, 2026, 5:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
CLPT
Jun 29, 2026, 4:42 PM EDT
Filing Type: 144
Importance Score:
7
CLPT
Jun 17, 2026, 4:31 PM EDT
Filing Type: 144
Importance Score:
7
CLPT
May 29, 2026, 5:24 PM EDT
Filing Type: 144
Importance Score:
7